Figure 1-3: Regional expression <strong>of</strong> transcription factors <strong>in</strong> <strong>the</strong> endoderm. Although <strong>the</strong>ir expression is here mapped<strong>in</strong> <strong>the</strong> chicken embryo, <strong>the</strong>ir homologs are expressed <strong>in</strong> a similar regional manner <strong>in</strong> <strong>the</strong> <strong>mouse</strong>. The transcriptionfactors shown on <strong>the</strong> left, mostly homeobox genes, are mapped to specific regions <strong>of</strong> <strong>the</strong> endoderm, as shown on <strong>the</strong>right.. These genes are not only regionally expressed <strong>in</strong> already shaped organs (as shown <strong>in</strong> <strong>the</strong> E4 chicken gut tube),but also <strong>in</strong> <strong>the</strong> endodermal sheet prior to organ formation, with stable expression doma<strong>in</strong>s that can be used as markers<strong>of</strong> presumptive regions. The top left p<strong>in</strong>k triangle shows Hex expression <strong>in</strong> <strong>the</strong> thyroid. The bottom left triangle refersto pancreas bud and <strong>the</strong> bottom right triangle to liver bud. BA1–4, branchial arches 1–4; Chicken CdxA = <strong>mouse</strong>Cdx2. Modified from (Grap<strong>in</strong>-Botton and Melton 2000).Pancreas and β cell formationPdx1 is expressed <strong>in</strong> <strong>the</strong> region <strong>of</strong> <strong>the</strong> gut tube where <strong>the</strong> pancreatic primordia start to bud aroundE8.75 (Figure 1-2C) and all pancreatic cell types derive from this PDX1-positive (PDX1 +hereafter) doma<strong>in</strong> (Jonsson et al. 1994). The ventral and dorsal buds form from <strong>the</strong> midl<strong>in</strong>e andlateral areas <strong>of</strong> <strong>the</strong> PDX1 + gut, respectively, <strong>the</strong>n grow and branch extensively before fus<strong>in</strong>g tobecome one pancreas by E12.5 (Figure 1-2D; (Jorgensen et al. 2007)). The ventral bud precedes<strong>the</strong> dorsal bud and expresses <strong>the</strong> Homeobox transcription factor HB9 (Hlxb9) and Pdx1concomitantly whereas <strong>the</strong> dorsal bud expresses <strong>the</strong>se sequentially and exclude sonic hedgehog(SHH)-<strong>signall<strong>in</strong>g</strong> (Hebrok et al. 1998). SHH repression allows pancreatic budd<strong>in</strong>g <strong>in</strong> this regionand is determ<strong>in</strong>ed by <strong>the</strong> underly<strong>in</strong>g notochord. Expression <strong>of</strong> <strong>the</strong> Pancreas-specific transcriptionfactor 1a subunit (Ptf1a; or p48) is limited to <strong>the</strong> dorsal and ventral epi<strong>the</strong>lium and is coexpressedwith Pdx1. The ventral pancreas develops <strong>in</strong> close association with <strong>the</strong> adjacent hepaticand bile duct endoderm and restriction <strong>of</strong> <strong>the</strong> ventral pancreas is dependent on TGFβ (SMAD2/3),BMP (SMAD1/5/8) and <strong>FGF</strong>-<strong>signall<strong>in</strong>g</strong> from <strong>the</strong> cardiac mesoderm (Deutsch et al. 2001; Rossi etal. 2001). TGFβ-<strong>signall<strong>in</strong>g</strong> is stable whereas <strong>FGF</strong> and BMP-<strong>signall<strong>in</strong>g</strong> are dynamic and canchange with<strong>in</strong> a few somite stages (Wandzioch and Zaret 2009). The dorsal pancreas does notshow active BMP or <strong>FGF</strong>-<strong>signall<strong>in</strong>g</strong> at this stage, but ra<strong>the</strong>r is specified by dynamic TGFβ-10
<strong>signall<strong>in</strong>g</strong>. These dynamic <strong>signall<strong>in</strong>g</strong> cascades possibly determ<strong>in</strong>e <strong>the</strong> boundaries <strong>of</strong> pancreaticendoderm, i.e. expression <strong>of</strong> Pdx1, and <strong>the</strong> closely related liver endoderm.As <strong>the</strong> pancreatic buds grow and branch, <strong>the</strong> surround<strong>in</strong>g mesenchyme secretes <strong>FGF</strong>10, whichstimulates pancreatic epi<strong>the</strong>lial proliferation. This mesenchymal stimulation is absolutelynecessary for ma<strong>in</strong>tenance <strong>of</strong> Pdx1 expression and pancreatic development, as <strong>FGF</strong>10 –/– show noPdx1 expression at E10.5 (Bhushan et al. 2001). The epi<strong>the</strong>lial expression <strong>of</strong> Pdx1 and NKhomeobox transcription factor 6.1 (Nkx6.1) starts to deviate <strong>in</strong>to NKX6.1 + <strong>cells</strong> found only <strong>in</strong> <strong>the</strong>central part <strong>of</strong> <strong>the</strong> epi<strong>the</strong>lium, whereas PDX1 + /NKX6.1 – <strong>cells</strong> are found at <strong>the</strong> periphery and atE13.5 mark <strong>the</strong> ac<strong>in</strong>i (Jorgensen et al. 2007). These ac<strong>in</strong>i become <strong>the</strong> exocr<strong>in</strong>e part <strong>of</strong> <strong>the</strong> pancreasthat produces and secretes digestive enzymes <strong>in</strong>to <strong>the</strong> connect<strong>in</strong>g ducts, releas<strong>in</strong>g <strong>the</strong>m to <strong>the</strong><strong>in</strong>test<strong>in</strong>e (Slack 1995). Neurogen<strong>in</strong> 3 (NGN3) + endocr<strong>in</strong>e precursors delam<strong>in</strong>ate from <strong>the</strong>epi<strong>the</strong>lium and develop <strong>in</strong>to Paired box gene 6 (Pax6)-express<strong>in</strong>g endocr<strong>in</strong>e <strong>cells</strong> which form <strong>the</strong>islets <strong>of</strong> Langerhans. The endocr<strong>in</strong>e <strong>cells</strong> <strong>in</strong> <strong>the</strong>se islets produce hormones, which <strong>the</strong>y secrete to<strong>the</strong> bloodstream. Islets consist <strong>of</strong> five cell types: α <strong>cells</strong> produc<strong>in</strong>g glucagon; β <strong>cells</strong> produc<strong>in</strong>g<strong>in</strong>sul<strong>in</strong>; δ <strong>cells</strong> produc<strong>in</strong>g somatostat<strong>in</strong>; ε <strong>cells</strong> produc<strong>in</strong>g ghrel<strong>in</strong> and PP <strong>cells</strong> produc<strong>in</strong>gpancreatic polypeptide. These islets have a dist<strong>in</strong>ct morphology, with <strong>the</strong> β <strong>cells</strong> <strong>in</strong> <strong>the</strong> centre and<strong>the</strong> o<strong>the</strong>r cell types at <strong>the</strong> periphery.Mouse <strong>ES</strong> <strong>cells</strong> <strong>in</strong> directed <strong>differentiation</strong>The <strong>in</strong>itial cell population used to generate β-like <strong>cells</strong> for cell replacement <strong>the</strong>rapy may comefrom ei<strong>the</strong>r somatic (or adult) stem <strong>cells</strong> or from <strong>ES</strong> <strong>cells</strong>. Somatic stem <strong>cells</strong> are mono- ormultipotent <strong>cells</strong> resid<strong>in</strong>g <strong>in</strong> most tissues and organs <strong>of</strong> <strong>the</strong> post-natal human. They are used <strong>in</strong> <strong>the</strong>treatment <strong>of</strong> leukaemia and o<strong>the</strong>r haematological malignancies through bone-marrowtransplantation. Additional areas under <strong>in</strong>vestigation <strong>in</strong>clude treatment <strong>of</strong> strokes, myocardial<strong>in</strong>farctions, corneal regeneration and epidermal gene <strong>the</strong>rapy (Pellegr<strong>in</strong>i et al. 2009; McCall et al.2010). There is no def<strong>in</strong>itive evidence <strong>of</strong> a somatic stem cell <strong>in</strong> <strong>the</strong> pancreas and thus <strong>the</strong> focus <strong>of</strong>cell replacement-<strong>the</strong>rapy for diabetes is currently on <strong>ES</strong> <strong>cells</strong> (Madsen 2005).<strong>ES</strong> <strong>cells</strong> are pluripotent <strong>cells</strong>, i.e. <strong>the</strong>y can give rise to all tissues <strong>of</strong> <strong>the</strong> embryo proper (Ohtsukaand Dalton 2008). They are isolated from <strong>the</strong> <strong>in</strong>ner cell mass <strong>of</strong> a blastocyst stage embryo andunder <strong>the</strong> right culture conditions <strong>the</strong>y can multiply <strong>in</strong>def<strong>in</strong>itely, while keep<strong>in</strong>g <strong>the</strong>ir pluripotentphenotype (Evans and Kaufman 1981; Mart<strong>in</strong> 1981; Y<strong>in</strong>g et al. 2003a). They hold great potentialdue to <strong>the</strong>ir pluripotent nature, but as yet, no protocol applicable to human treatment has beendeveloped.Modell<strong>in</strong>g <strong>differentiation</strong> us<strong>in</strong>g <strong>mouse</strong> <strong>ES</strong> <strong>cells</strong>Mouse <strong>ES</strong> (m<strong>ES</strong>) <strong>cells</strong> are used for <strong>the</strong> study <strong>of</strong> directed <strong>differentiation</strong> <strong>towards</strong> def<strong>in</strong>itiveendoderm, pancreatic foregut and ultimately β-like <strong>cells</strong> because <strong>the</strong>y have certa<strong>in</strong> advantages.Work<strong>in</strong>g with m<strong>ES</strong> <strong>cells</strong> holds fewer ethical concerns than work<strong>in</strong>g with human <strong>ES</strong> (h<strong>ES</strong>) <strong>cells</strong>and <strong>the</strong>re are many available tools, such as transgenic m<strong>ES</strong> cell l<strong>in</strong>es which can be used to testhypo<strong>the</strong>ses that cannot be o<strong>the</strong>rwise experimentally tested. Also, <strong>mouse</strong> embryonic developmentclosely mimics human embryonic development, suggest<strong>in</strong>g that conclusions may be extrapolatedand applied to <strong>the</strong> human system. But <strong>in</strong> us<strong>in</strong>g m<strong>ES</strong> <strong>cells</strong> for scientific purposes, it is important tobear <strong>in</strong> m<strong>in</strong>d that <strong>the</strong> end product will always be a cell <strong>the</strong>rapy based on h<strong>ES</strong> <strong>cells</strong>, and f<strong>in</strong>d<strong>in</strong>gswill <strong>the</strong>refore always have to be confirmed <strong>in</strong> this system. The sections below will focus on m<strong>ES</strong><strong>cells</strong> with examples from h<strong>ES</strong> cell work where relevant.Derivation <strong>of</strong> m<strong>ES</strong>CsThe first m<strong>ES</strong> <strong>cells</strong> were derived almost 30 years ago and <strong>the</strong> first h<strong>ES</strong> cell l<strong>in</strong>e was derived 12years ago (Evans and Kaufman 1981; Mart<strong>in</strong> 1981; Thomson et al. 1998). m<strong>ES</strong> <strong>cells</strong> (<strong>ES</strong> <strong>cells</strong>hereafter) are used ei<strong>the</strong>r for generation <strong>of</strong> transgenic mice or for cultur<strong>in</strong>g and <strong>differentiation</strong> <strong>of</strong>(transgenic) cell l<strong>in</strong>es. Mouse <strong>ES</strong> <strong>cells</strong> are derived from <strong>the</strong> ICM <strong>of</strong> <strong>the</strong> E3.5 blastocyst. They aregrown on feeder <strong>cells</strong> <strong>in</strong> <strong>the</strong> presence <strong>of</strong> serum and leukemia <strong>in</strong>hibitory factor (LIF), whichma<strong>in</strong>ta<strong>in</strong>s <strong>the</strong>m pluripotent.11
- Page 1: PhD thesisCand.scient. Janny Marie
- Page 5: ResuméSukkersyge er en sygdom der
- Page 9: Table of contents1
- Page 12 and 13: ICMinner cell massIdInhibitor of di
- Page 14 and 15: cell mass regenerates probably thro
- Page 16 and 17: Figure 1-1: Early embryo developmen
- Page 20 and 21: The pluripotent stateThe pluripoten
- Page 25 and 26: There are four membrane-bound FGFRs
- Page 27: 2. AimsThe aim of this study was to
- Page 30 and 31: Developmental Biology 330 (2009) 28
- Page 32 and 33: 288 M. Hansson et al. / Development
- Page 34 and 35: 290 M. Hansson et al. / Development
- Page 36 and 37: 292 M. Hansson et al. / Development
- Page 38 and 39: 294 M. Hansson et al. / Development
- Page 40 and 41: 296 M. Hansson et al. / Development
- Page 42 and 43: 298 M. Hansson et al. / Development
- Page 44 and 45: 300 M. Hansson et al. / Development
- Page 46 and 47: 302 M. Hansson et al. / Development
- Page 48 and 49: 304 M. Hansson et al. / Development
- Page 50 and 51: Figure S2Figure S2: A subpopulation
- Page 52 and 53: Figure S4Figure S4: Expression of T
- Page 54 and 55: Figure S6Figure S6: qRT-PCR analyse
- Page 56 and 57: epithelium; Cdx2, expressed posteri
- Page 58 and 59: Figure 4-4: A high FGF4-concentrati
- Page 60 and 61: Figure 4-6: A 3-step protocol does
- Page 63 and 64: 5. Paper IIFGFR(IIIc)-activation in
- Page 65 and 66: AbstractProgress in embryonic stem
- Page 67 and 68: variants in their Ig-like domain II
- Page 69 and 70:
Cell count and proliferation assayC
- Page 71 and 72:
influence on the numbers of Sox17-G
- Page 73 and 74:
undifferentiated cells, we found th
- Page 75 and 76:
FGF4, 5, FGF8b and FGFR1, are expre
- Page 77 and 78:
with EdU-stain (blue sample); and w
- Page 79 and 80:
Olsen, S.K., J.Y. Li, C. Bromleigh,
- Page 81 and 82:
FiguresFigure 1: Screen for FGFR-is
- Page 83 and 84:
Figure 3: Activation of FGFRb or FG
- Page 87 and 88:
Opposite, Figure 6: In the absence
- Page 89 and 90:
6. General discussionEndoderm diffe
- Page 91 and 92:
Overall, the multitude of FGF-signa
- Page 93 and 94:
transplantation is the spread of an
- Page 96:
AcknowledgementsThe work presented
- Page 99 and 100:
Chambers, I., D. Colby, M. Robertso
- Page 101 and 102:
Hawkins, V.J. Wroblewski, D.S. Li,
- Page 103 and 104:
Nishikawa, S.I., S. Nishikawa, M. H
- Page 105 and 106:
Tanimizu, N., H. Saito, K. Mostov,